Ana Abecasis

3.1k total citations
105 papers, 1.7k citations indexed

About

Ana Abecasis is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Ana Abecasis has authored 105 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Infectious Diseases, 63 papers in Virology and 25 papers in Epidemiology. Recurrent topics in Ana Abecasis's work include HIV Research and Treatment (62 papers), HIV/AIDS drug development and treatment (47 papers) and HIV/AIDS Research and Interventions (44 papers). Ana Abecasis is often cited by papers focused on HIV Research and Treatment (62 papers), HIV/AIDS drug development and treatment (47 papers) and HIV/AIDS Research and Interventions (44 papers). Ana Abecasis collaborates with scholars based in Portugal, Belgium and Germany. Ana Abecasis's co-authors include Anne–Mieke Vandamme, Ricardo Camacho, Koen Deforche, Pieter Libin, Philippe Lemey, Andrea-Clemencia Pineda-Peña, Perpétua Gómes, Nuno R. Faria, Túlio de Oliveira and Kristof Theys and has published in prestigious journals such as The Lancet, Bioinformatics and PLoS ONE.

In The Last Decade

Ana Abecasis

98 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Abecasis Portugal 21 1.2k 1.1k 417 249 203 105 1.7k
Gonzalo Bello Brazil 24 1.3k 1.1× 1.1k 1.1× 401 1.0× 120 0.5× 380 1.9× 118 1.8k
África Holguín Spain 27 1.7k 1.4× 1.5k 1.4× 575 1.4× 245 1.0× 138 0.7× 116 2.3k
Katrina Lythgoe United Kingdom 19 769 0.6× 278 0.3× 342 0.8× 239 1.0× 256 1.3× 38 1.5k
Francesco Vairo Italy 26 993 0.8× 572 0.5× 640 1.5× 505 2.0× 705 3.5× 84 2.1k
Matilu Mwau Kenya 23 763 0.6× 496 0.5× 404 1.0× 239 1.0× 220 1.1× 78 1.4k
S. Brunet France 22 680 0.6× 493 0.5× 325 0.8× 86 0.3× 59 0.3× 58 1.2k
Sean Philpott United States 18 667 0.5× 739 0.7× 208 0.5× 181 0.7× 180 0.9× 39 1.3k
Nicole Vidal France 26 1.4k 1.1× 1.4k 1.3× 443 1.1× 189 0.8× 82 0.4× 73 1.9k
Philippe Mauclère France 30 977 0.8× 1.3k 1.2× 858 2.1× 143 0.6× 193 1.0× 65 2.5k
Angela R. McLean United Kingdom 16 420 0.3× 529 0.5× 146 0.4× 303 1.2× 120 0.6× 24 1.2k

Countries citing papers authored by Ana Abecasis

Since Specialization
Citations

This map shows the geographic impact of Ana Abecasis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Abecasis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Abecasis more than expected).

Fields of papers citing papers by Ana Abecasis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Abecasis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Abecasis. The network helps show where Ana Abecasis may publish in the future.

Co-authorship network of co-authors of Ana Abecasis

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Abecasis. A scholar is included among the top collaborators of Ana Abecasis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Abecasis. Ana Abecasis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abecasis, Ana, et al.. (2024). Adherence to antiretroviral therapy among HIV-1 patients from sub-Saharan Africa: a systematic review. PubMed. 26(3). 102–110. 1 indexed citations
2.
Pimentel, Victor, Marta Pingarilho, Cruz S. Sebastião, et al.. (2024). Applying Next-Generation Sequencing to Track HIV-1 Drug Resistance Mutations Circulating in Portugal. Viruses. 16(4). 622–622. 4 indexed citations
3.
Pimentel, Victor, et al.. (2024). Sociodemographic and clinical features related to hepatitis B virus infection among rejected blood donors in Luanda, Angola. Health Science Reports. 7(8). e2287–e2287. 2 indexed citations
4.
Bassat, Quique, Mario Raviǵlione, Ana Abecasis, et al.. (2024). Europe needs to urgently implement an outward looking Global Health Strategy. The Lancet Regional Health - Europe. 45. 101046–101046.
5.
6.
Pimentel, Victor, Marta Pingarilho, Sandra Bianchini Fernandes, et al.. (2022). Differential patterns of post-migration HIV-1 infection acquisition among Portuguese immigrants of different geographical origin. Revista de Estudos Anglo-Portugueses/Journal of Anglo-Portuguese Studies. 3 indexed citations
7.
Abecasis, Ana, et al.. (2022). Determinants of Late HIV Presentation at Ndlavela Health Center in Mozambique. International Journal of Environmental Research and Public Health. 19(8). 4568–4568. 14 indexed citations
8.
Rossetti, Barbara, Massimiliano Fabbiani, Domenico Di Carlo, et al.. (2022). Effectiveness of integrase strand transfer inhibitors in HIV‐infected treatment‐experienced individuals across Europe. HIV Medicine. 23(7). 774–789. 4 indexed citations
9.
Mertens, T., Ana Lúcia Teixeira, Helena Loureiro, et al.. (2022). Cohort profile: Health trajectories of Immigrant Children (CRIAS)–a prospective cohort study in the metropolitan area of Lisbon, Portugal. BMJ Open. 12(10). e061919–e061919. 2 indexed citations
10.
Rossetti, Barbara, Massimiliano Fabbiani, Domenico Di Carlo, et al.. (2021). Effectiveness of integrase strand transfer inhibitor-based regimens in HIV-infected treatment-naive individuals: results from a European multi-cohort study. Journal of Antimicrobial Chemotherapy. 76(9). 2394–2399. 6 indexed citations
11.
Mendes, Tiago Manuel Fernandes, Ana Abecasis, Silvana Belo, et al.. (2021). A Comparative Proteomic Analysis of Praziquantel-Susceptible and Praziquantel-Resistant Schistosoma mansoni Reveals Distinct Response Between Male and Female Animals. Revista de Estudos Anglo-Portugueses/Journal of Anglo-Portuguese Studies. 2. 4 indexed citations
12.
Pingarilho, Marta, Victor Pimentel, Sandra Bianchini Fernandes, et al.. (2020). Increasing Prevalence of HIV-1 Transmitted Drug Resistance in Portugal: Implications for First Line Treatment Recommendations. Viruses. 12(11). 1238–1238. 11 indexed citations
13.
Pimentel, Victor, Marta Pingarilho, Sandra Fernandes, et al.. (2020). Molecular Epidemiology of HIV-1 Infected Migrants Followed Up in Portugal: Trends between 2001–2017. Viruses. 12(3). 268–268. 13 indexed citations
14.
Libin, Pieter, Koen Deforche, Ana Abecasis, & Kristof Theys. (2018). VIRULIGN: fast codon-correct alignment and annotation of viral genomes. Bioinformatics. 35(10). 1763–1765. 40 indexed citations
15.
Theys, Kristof, Pieter Libin, Kai Dallmeier, et al.. (2017). Zika genomics urgently need standardized and curated reference sequences. PLoS Pathogens. 13(9). e1006528–e1006528. 6 indexed citations
16.
Abecasis, Ana, Kristel Van Laethem, Koen Deforche, et al.. (2008). Impact of HIV-1 protease mutations A71V/T and T74S on M89I/V-mediated protease inhibitor resistance in subtype G isolates. Journal of Antimicrobial Chemotherapy. 61(6). 1201–1204. 14 indexed citations
17.
Abecasis, Ana, Philippe Lemey, Nicole Vidal, et al.. (2007). Recombination Confounds the Early Evolutionary History of Human Immunodeficiency Virus Type 1: Subtype G Is a Circulating Recombinant Form. Journal of Virology. 81(16). 8543–8551. 68 indexed citations
18.
Camacho, Ricardo, et al.. (2005). Different substitutions under drug pressure at protease codon 82 in HIV-1 subtype G compared to subtype B infected individuals including a novel 182M resistance mutation. Antiviral Therapy. 10(4). 138. 16 indexed citations
19.
Camacho, R, Koen Deforche, Kristel Van Laethem, et al.. (2004). Nelfinavir resistance in HIV-1 subtype B and G infected patients: evidence for different pathways and novel mutations associated with failure of nelfinavir based regimens. Antiviral Therapy. 9(4). 3 indexed citations
20.
Abecasis, Ana, Perpétua Gómes, Inge Derdelinckx, et al.. (2003). L891/V: a novel mutation selected by protease inhibitor therapy in subtype G, but not in subtype B-infected patients. Antiviral Therapy. 8(3). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gonzalo Bello Breakdown of academic impact, for papers by África Holguín Breakdown of academic impact, for papers by Katrina Lythgoe Breakdown of academic impact, for papers by Francesco Vairo Breakdown of academic impact, for papers by Matilu Mwau Breakdown of academic impact, for papers by S. Brunet Breakdown of academic impact, for papers by Sean Philpott Breakdown of academic impact, for papers by Nicole Vidal Breakdown of academic impact, for papers by Philippe Mauclère Breakdown of academic impact, for papers by Angela R. McLean
Rankless by CCL
2026